Analysts expect Q1 2026 revenue of around $622 million, a 29.8% increase from $479 million in Q1 2025. Consensus non-GAAP EPS is projected at $0.23, up 43.8% year-over-year from $0.16.
NET stock rose +13% over the past 30 days, driven by anticipation ahead of Q1 2026 earnings and positive analyst sentiment on AI infrastructure growth. Over the past quarter, the stock gained +41%, reflecting recovery from early-year volatility amid strong Q4 2025 earnings momentum and cybersecurity demand.
Synopsys stock surged +26% over the last 30 days, driven by strong Q1 earnings beat, Ansys acquisition integration progress, and partnerships with TSMC and NASA. Over the past quarter, shares rose +21%, recovering from earlier lows amid AI demand in semiconductor design and positive analyst sentiment.
CRWV stock surged +58% over the past 30 days, driven by major AI partnerships including a $21 billion expanded deal with Meta and multi-year agreements with Anthropic and Jane Street. Over the past quarter, shares rose +42%, reflecting analyst upgrades, strong revenue backlog growth to $66.8 billion, and sustained AI infrastructure demand.
PLTR shares declined 5.89% to $137.43 during today's trading session, following a close of $146.03 on the prior session. Primary catalyst: Investor disappointment over a slight miss in U.
Palantir reported Q1 2026 revenue of $1.63 billion, up 85% year-over-year, beating consensus estimates of $1.54 billion. Adjusted EPS came in at $0.33, surpassing expectations of $0.28, with GAAP EPS at $0.34.
CRWD stock rose approximately +15% over the past 30 days, driven by analyst upgrades and recognition as a leader in cyberthreat intelligence. Over the past quarter, the stock gained around +8%, recovering from earlier AI competition fears amid strong Q4 earnings.
XNDU shares plunged 59.60% to $14.59 from the previous close of $36.12. Primary catalyst: SEC filing registering 293.6 million Class B subordinate voting shares for resale by selling securityholders.
DVLT shares dropped approximately 18% in premarket trading on May 5, 2026, from the prior Friday close of $0.74 to around $0.61. The primary catalyst is the company's announcement of a $60 million public offering of 109,090,910 shares of common stock, expected to close around May 5, 2026 — a heavily dilutive transaction for existing shareholders.
ORCL stock rose approximately +18% over the past 30 days, driven by AI-related deals and renewed investor interest in cloud infrastructure growth. Over the past quarter, shares gained around +17%, supported by a strong Q3 earnings beat with cloud revenue surging 44% year-over-year.
Microsoft (MSFT) stock rose approximately +11% over the last 30 days, driven by a strong fiscal Q3 earnings beat highlighting robust cloud and AI growth. Over the past quarter, the stock ended relatively flat at +0.1%, amid high volatility from earlier selloffs tied to capital expenditure (capex) concerns followed by a solid recovery.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
PANW stock rose approximately +11% over the past 30 days, driven by recovery in cybersecurity sentiment and strong enterprise wins. Over the past quarter, shares gained +3% amid volatility, reflecting a post-earnings dip followed by steady rebound.
Synopsys stock surged +21% over the past 30 days amid a sharp rally driven by renewed AI semiconductor demand and bullish analyst updates. Over the past quarter, shares rose +15% despite high volatility, reflecting post-earnings digestion and subsequent recovery.
CHKP shares are plunging approximately 12% in premarket trading on April 30, 2026, falling from a prior session close of roughly $139.96 to around $123.16. The primary catalyst is a mixed Q1 2026 earnings report — a non-GAAP EPS beat was overshadowed by a meaningful revenue miss, with reported revenue of $668 million falling short of the Wall Street consensus of approximately $672.62 million.
CPAY stock rose +9.8% over the last 30 days, rebounding from late March lows amid reaffirmed guidance and positive partnerships. Over the past quarter, shares declined -1.5%, reflecting volatility after an early post-earnings rally and a strategic asset sale.
Analysts expect Q3 FY2026 revenue of $81.43 billion, representing 16% year-over-year growth, aligning closely with company guidance of $80.65-81.75 billion. Consensus earnings per share (EPS) estimate is $4.07, up approximately 18% from the prior year.
STNE stock declined approximately 15% over the past 30 days, primarily due to a sharp drop on the ex-dividend date following an extraordinary $2.53 per share cash dividend announcement. Over the past quarter, the stock fell around 25%, reflecting heightened volatility amid mixed market sessions and analyst adjustments.
STNE shares are trading approximately 14% lower in premarket on April 24, 2026, with the stock dropping from a prior close of roughly $14.55 to around $12.23–$12.45. The primary driver of the decline is a mechanical ex-dividend price adjustment: today is the official ex-dividend date for StoneCo's extraordinary $2.53 per share cash dividend.
Shares of WEX are declining approximately 16.07% in Thursday's session on April 23, 2026, falling from a prior close of approximately $211.37 to approximately $177.53, as investors responded to the company's Q1 2026 earnings report and management conference call with a decisive repricing of full-year growth expectations.